Ocular Therapeutix Inc (OCUL)
Healthcare
Biotechnology
8.40 $
+2.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -67 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 | -22 | -34 | -25 | -37 | -39 | -45 | -55 | -51 | -54 | -66 | -67 | -238 | |
| 0.9 | 1.0 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | 1.9 | 5.5 | |
| 4.5 | 4.3 | 8.0 | 11 | 6.6 | 7.2 | 10 | 9.7 | 12 | 11 | 16 | 15 | 53 | |
| 6.2 | -6.6 | -13 | 3.1 | -1.2 | 0.9 | 5.5 | 0.6 | 3.7 | -2.1 | 1.0 | -1.0 | 1.6 | |
| 0.3 | 0.5 | 0.3 | 0.7 | 0.1 | 0.2 | 1.9 | 1.2 | 6.0 | 2.8 | 4.7 | 3.4 | 17 | |
| -0.3 | -0.5 | -0.3 | -0.7 | -0.1 | -0.2 | -1.9 | -1.1 | -6.0 | -2.8 | -4.7 | -3.4 | -17 | |
| – | 0.9 | – | – | 0.5 | – | – | 0.7 | – | – | – | 0.9 | – | |
| – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 57 | 108 | 321 | 2.2 | 4.2 | 4.5 | 4.2 | 98 | 10 | 449 | 0.3 | 2.6 | 463 | |
| 44 | 85 | 287 | -23 | -32 | -35 | -42 | 41 | -46 | 392 | -70 | -68 | 208 | |
| -13 | -23 | -34 | -26 | -37 | -40 | -47 | -56 | -57 | -57 | -71 | -71 | -255 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.